In vitro secretion of cytokines by human bone marrow: Effects of age and estrogen status

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 6, 1998, Pages 2043-2051

  Cheleuitte, Domingo ^a   Mizuno, Shuichi ^a   Glowacki, Julie ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; INTERLEUKIN 1BETA; INTERLEUKIN 6;

AGE; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; ESTROGEN METABOLISM; FEMALE; HUMAN; HUMAN CELL; MALE; OSTEOBLAST; OSTEOCLAST; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; AGING; BONE MARROW CELLS; CELLS, CULTURED; CYTOKINES; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; INSULIN; INTERLEUKIN-1; INTERLEUKIN-11; INTERLEUKIN-6; MALE; MIDDLE AGED; POSTMENOPAUSE; SELENIUM; TRANSFERRIN;

EID: 0031732988     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.6.2043     Document Type: Article

References (36)

1. Manolagas SC, Jilka RL. 1995 Bone marrow, cytokines, and bone remodeling. N Engl J Med. 332:305-311.
2. Pacifici R. 1996 Estrogen, cytokine, and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res. 11:1043-1051.
3. Horowotz MC. 1993 Cytokines and estrogen in bone: anti-osteoporotic effects. Science. 260:626-627.
4. Bot FJ, van Eijk L, Broeders L, Aarden LA, Löwenberg B. 1989 Interleukin-6 synergizes with M-CSF in the formation of macrophage colonies from purified human marrow progenitor cells. Blood. 73:435-437.
5. Caracciolo D, Clark SC, Rovera G. 1989 Human interleukin-6 supports granulocytic differentiation of hematopoietic progenitor cells and acts synergistically with GM-CSF. Blood. 73:666-670.
6. Schibler KR. 1992 Effect of interleukin-11 on cycling status and clonogenic maturation of fetal and adult hematopoietic progenitors. Blood. 80:900-903.
7. Kotake S, Sato K, Kim KJ, et al. 1996 Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation. J Bone Miner Res. 11:88-95.
8. Roodman GD. 1995 Application of bone marrow cultures to the study of osteoclast formation and osteoclast precursors in man. Calcif Tissue Int. 56(Suppl 1):S22-S23.
9. Fibbe WE, van Damme J, Billiau A, et al. 1988 Interleukin 1 induces human marrow stromal cells in long-term culture to produce granulocyte colony-stimulating factor and macrophage colony-stimulatung factor. Blood. 71:430-435.
10. Caldwell J, Emerson SG. 1994 IL-1α and TNFα act synergistically to stimulate production of myeloid colony-stimulating factors by cultured human bone marrow stromal cells and cloned stromal cell strains. J Cell Physiol. 159:221-228.
11. Yang YC, Tsai S, Wong GG, Clark SC. 1988 Interleukin-1 regulation of hematopoietic growth factor production by human stromal fibroblasts. J Cell Physiol. 134:292-296.
12. Neumanitis J, Andrews DF, Mochizuki DY, Lilly MB, Singer JW. 1989 Human marrow stromal cells: response to interleukin-6 (IL-6) and control of IL-6 expression. Blood. 74:1929-1935.
13. Guba SC, Sartor CI, Gottschalk LR, Ye-Hu J, Mulligan T, Emerson SG. 1992 Bone marrow stromal fibroblasts secrete interleukin-6 and granulocyte-macrophage colony-stimulating factor in the absence of inflammatory stimulation: demonstration by serum-free bioassay, enzyme-linked immunosorbent assay, and reverse transcriptase polymerase chain reaction. Blood. 80:1190-1198.
14. Kurihara N, Bertolini D, Suda T, Akiyama Y, Roodman GD. 1990 IL-6 stimulates osteoclast-like multinucleated cell formation in long term human marrow cultures by inducing IL-1 release. J Immunol. 144:4226-4230.
15. Schaafsma MR, Fibbe WE, van Damme J, et al. 1989 Interleukin-6 is not involved in the interleukin-1 -induced production of colony-stimulating factors by human bone marrow stromal cells and fibroblasts. Blood. 74:2619-2623.
16. Rifas L, Kenney JS, Marcelli M, et al. 1995 Production of interleukin-6 in human osteoblasts and human bone marrow stromal cells: evidence that induction by interleukin-1 and tumor necrosis factor-α is not regulated by ovarian steroids. Endocrinology. 136:4056-4067.
17. Girasole G, Jilka RL, Passen G, et al. 1992 17β-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens. J Clin Invest. 89:883-891.
18. Kassem M, Harris SA, Spelsberg TC, Riggs BL. 1996 Estrogen inhibits interleukin-6 production and gene expression in a human osteoblastic cell line with high levels of estrogen receptors. J Bone Miner Res. 11:193-199.
19. West DC, Sattar A, Kumar S. 1985 Asimplified in situ solubilization procedure for the determination of DNA and cell number in tissue cultured mammalian cells. Anal Biochem. 147:289-295.
20. Long MW, Williams JL, Mann KG. 1989 Expression of human bone-related proteins in the hematopoietic microenvironment. J Clin Invest. 86:1387-1395.
21. Glowacki J. 1995 Influence of age on human marrow. Calcif Tissue Int. 56(Suppl 1):S50-S51.
22. Mundy GR. 1992 Local factors regulating osteoclast function. In: Rifkin BR, Gay CV, eds. Biology and physiology of the osteoclast. Boca Raton: CRC Press; 185-227.
23. Jilka RL, Hangoc G, Girasole G, et al. 1992 Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science. 257:88-91.
24. Miyaura C, Kusano K, Masuzawa T, et al. 1995 Endogenous bone-resorbing factors in estrogen deficiency: cooperative effects of IL-1 and IL-6. J Bone Miner Res. 10:1365-1373.
25. Kitazawa R, Kimble RB, Vannice JL, Rung VT, Pacifici R. 1994 Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice. J Clin Invest. 94:2397-2406.
26. Girasole G, Passen G, Jilka RL, Manolagas SC. 1994 Interleukin-11: a new cytokine critical for osteoclast development. J Clin Invest. 93:1516-1524.
27. Girasole G, Pedrazzoni M, Giuliani N, Passeri G, Passeri M. 1995 Increased serum soluble interleukin-6 receptors levels are induced by ovariectomy, prevented by estrogen replacement and reversed by alendronate administration. J Bone Miner Res. 10:S160.
28. Pedrazzoni M, Girasole G, Giuliani N, et al. 1997 Serum interleukin-6, soluble IL-6 receptors, and soluble gp 130 exhibit different patterns of age-and menopause-related changes. J Bone Miner Res. 12:S112.
29. Cohen-Solal ME, Graulet AM, Gueris J, et al. 1995 Bone resorption at the femoral neck is dependent on local factors in nonosteoporotic late postmenopausal women: an in vitro-in vivo study. J Bone Miner Res. 10:307-314.
30. Cohen-Solal ME, Court C, Morieux C, et al. 1998 Cytokine release from marrow mononuclear cells in negatively correlated to cortical elasticity in non-osteoporotic postmenopausal women. Calcif Tissue Int. 62:13-16.
31. Bismar H, Diel I, Ziegler R, Pfeilschifter J. 1995 Increased cytokine secretion by human bone marrow cells after menopause or discontinuation of estrogen replacement. J Clin Endocrinol Metab. 80:3351-3355.
32. + cells in serum-free cultures initiated with highly purified progenitor cells from human bone marrow. J Exp Med. 175:1501-1509.
33. Glowacki J, Yates K, Lesieur-Brooks A, Bleiberg I, Cheleuitte D. 1997 Confounding influences of culture conditions on cytokine secretion by cultured primary human bone marrow cells. J Bone Miner Res. 12:5437.
34. Klein B, Zhang X, Jourdan M, et al. 1989 Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6. Blood. 73:517-526.
35. Takahashi S, Reddy SV, Dallas M, Devlin R, Chou JY, Roodman GD. 1995 Development and characterization of a human marrow stromal cell line that enhances osteoclast-like cell formation. Endocrinology. 136:1441-1449.
36. Rosen CJ, Verault D, Stef fens C, Cheleuitte D, Glowacki J. 1997 Effects of age and estrogen status on the skeletal IGF regulatory system: studies with human marrow. Endocrine. 7:77-80.